Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
SPRYARS Pharmaceuticals	$1.79bn	n/a	n/a
AMAMAmbrx Biopharma	$1.76bn	n/a	n/a
CNTACentessa Pharmaceuticals	$1.75bn	n/a	n/a
GRALGrail	$1.74bn	n/a	n/a
BEAMBeam Therapeutics	$1.69bn	n/a	n/a
VERAVera Therapeutics	$1.44bn	n/a	n/a
ETNB89bio	$1.44bn	n/a	n/a
BHVNBiohaven	$1.44bn	n/a	n/a
AZTAAzenta	$1.40bn	n/a	n/a
EWTXEdgewise Therapeutics	$1.39bn	n/a	n/a
JANXJanux Therapeutics	$1.37bn	n/a	n/a
CLDXCelldex Therapeutics	$1.35bn	n/a	n/a
PNTPOINT Biopharma Global	$1.33bn	14.99	n/a
TVTXTravere Therapeutics	$1.31bn	n/a	n/a
EXAIExscientia	$1.24bn	n/a	n/a
GPCRStructure Therapeutics	$1.21bn	n/a	n/a
CVACCureVac NV	$1.21bn	5.69	n/a
CTICCTI Biopharma	$1.20bn	n/a	n/a
DVAXDynavax Technologies	$1.19bn	n/a	n/a
ELVNEnliven Therapeutics	$1.19bn	n/a	n/a